Why the study?
Most studies show sex-differentiated outcomes favoring men after PCI, prompting investigation into the age-adjusted impact of sex on long-term outcomes.
Does female sex compared to male sex affect the risk of MACE in patients undergoing percutaneous coronary intervention?
Does female sex compared to male sex affect the risk of MACE in patients undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
After adjusting for age and risk factors, female sex is not associated with a poorer long-term outcome than male sex following percutaneous coronary intervention.
BACKGROUND: Currently, the sex-differentiated outcome after percutaneous coronary intervention (PCI) favors male sex in most studies. In this study, we aimed to investigate the age-adjusted impact of sex on long-term outcome. METHODS: The study was an observational, prospective, multicenter, cohort study with pooling of 5-year results of the randomized controlled all-comer stent trials SORT OUT (Scandinavian Organization for Randomized Trials With Clinical Outcome) III, V, VI, VII, VIII, and IX conducted from 2006 to 2017. All patients were followed for 5 years. The predefined main outcome was a major adverse cardiac event (MACE); a composite end point comprising all-cause death, spontaneous myocardial infarction, and target lesion revascularization assessed by a clinical event committee. MACE difference across sex was assessed by incidence rate ratios at 5 years adjusted for age and predefined risk factors. RESULTS: In total, 15 242 patients (women, 3729 [24.5%]) with a mean age of 67.8±11.0 years were included in the study, with 0.2% lost to follow-up. Compared with men, women were older (women, 67.8±11.0 years; men, 64.8±10.7 years), had more hypertension and dyslipidemia but less previous MI and revascularization. MACEs occurred in 747 (21.8%) of the women and 2196 (20.5%) of the men at 5 years (unadjusted incidence rate ratio, 1.07 [95% CI, 0.98-1.16]; and adjusted incidence rate ratio, 0.91 [95% CI, 0.84-0.99]). Female sex was not associated with an increased risk in any of the individual MACE components. CONCLUSIONS: Female sex was not associated with a poorer long-term outcome than male sex after treatment for coronary artery disease with percutaneous coronary intervention in MACEs or any of the individual components.
No takes yet. Share an insight, caveat, or question.
Holck et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: